Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea
Henry Schein Dental's Sleep Complete program provides tools to address all of the key components of dental sleep medicine: education, treatment, reimbursement and monitoring. The Sleep Complete package includes the Dental Writer™ Diagnostic Report Writer and Medical Billing Software for Dentistry through Nierman Practice Management. This specialty software simplifies the billing and reimbursement process for dentists on procedures that require reimbursement from the patients' medical insurance and provides the tools needed to easily submit reimbursement paperwork at the click of a button. Additionally, as part of the Sleep Complete package, Henry Schein Dental is offering dentists registration to the Nierman Practice Management two-day "Successful Implementation of Dental Sleep Medicine" seminars featuring Dr.
The Sleep Complete package also includes the oral appliance starter kit from
The final component of the Sleep Complete package is the WatchPAT™ testing device provided through Itamar Medical. WatchPAT is a user-friendly, non-invasive, portable sleep testing device that gathers data related to the patient's sleep tendencies that can be interpreted by a sleep physician and used by the dentist to titrate the oral appliance being used for the treatment of obstructive sleep apnea. Dentists utilize the WatchPAT portable sleep monitoring device in collaboration with the patient's physician.
"Sleep apnea is a serious health problem, and dental sleep medicine presents a very promising practice extension opportunity for dentists," said
Sleep apnea, which occurs when the tongue and soft tissues fall back into the throat and block the airway during sleep, is a very serious health condition. According to the
The Sleep Complete package will be offered to dentists through a bundled financing package through
About Henry Schein, Inc.
Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of health care products and services to office-based practitioners, is a Fortune 500® company and a member of the NASDAQ 100® Index. The Company is recognized for its excellent customer service and highly competitive prices. Henry Schein's five businesses – Dental, Medical,
Headquartered in
In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: recently enacted healthcare legislation; effects of a highly competitive market; changes in the healthcare industry; changes in regulatory requirements; risks from expansion of customer purchasing power and multi-tiered costing structures; risks associated with our international operations; fluctuations in quarterly earnings; our dependence on third parties for the manufacture and supply of our products; transitional challenges associated with acquisitions, including the failure to achieve anticipated synergies; financial risks associated with acquisitions; regulatory and litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from disruption to our information systems; general economic conditions; decreased customer demand and changes in vendor credit terms; disruptions in financial markets; our dependence upon sales personnel, manufacturers and customers; our dependence on our senior management; possible increases in the cost of shipping our products or other service issues with our third-party shippers; risks from rapid technological change; possible volatility of the market price of our common stock; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.
We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.
SOURCE Henry Schein, Inc.
Susan Vassallo, Vice President, Corporate Communications, +1-631-843-5562, susan.vassallo@henryschein.com